Liberalization of Visiting Policies in ICU for Reducing High Risk of Post-traumatic Stress Disorder

NCT ID: NCT03846323

Last Updated: 2019-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1289 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-18

Study Completion Date

2018-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This was a cluster randomized study of an ICU level intervention to reduce high risk of post-traumatic stress disorder (PTSD) in family members of ICU patients.

Participating ICUs had restrictive visiting policies (i.e., \<6 hours/day) before randomization.

After an observational period and a washout period, participating ICUs were randomized either to maintain their visiting policies or to liberalize their visiting policies (24 hours a day, 7 days a week.)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Family members of ICU patients are particularly exposed to anxiety, depressive, acute stress disorder, and posttraumatic stress disorder symptoms (PTSD).

It is currently unknown what type of interventions/ strategies to cope with postintensive care syndrome family would produce the best improvement. Experts suggest that symptoms in family members are potentially amenable to intervention by ICU staff. One intervention to reduce PTSD could be a liberalization of the visiting hours. However, restrictions on visiting hours in the intensive care unit (ICU) are usually adopted worldwide.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PTSD in Family Members of ICU Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Visiting policies: open 24h/24

Visiting policies: 24 hours a day, 7 days a week

Group Type EXPERIMENTAL

Visiting policies: 24 hours a day, 7 days a week

Intervention Type OTHER

Restriction of visiting policies

Restriction of visiting policies \< 6 hours

Group Type OTHER

Restriction of visiting policies < 6 hours

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Visiting policies: 24 hours a day, 7 days a week

Intervention Type OTHER

Restriction of visiting policies < 6 hours

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient and family member \> 18 years or older,

* mechanical ventilation expected for more than 48 h and inclusion between day 3 and 5 from the beginning of mechanical ventilation,
* patient having a family member speaking and understanding French, and with the ability to visit his/her relative during the ICU stay,
* patient and his/her relative consenting to participate in the study, or obtention of family consent in case of patient incompetency

Exclusion Criteria

\- Patient without family available or family not speaking or understanding French"
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

LILA BOUADMA

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AOM08226

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ICU-VR Prior to ICU Admission
NCT06642636 RECRUITING NA
Diary for Severe Trauma
NCT02305303 COMPLETED NA